ACTH- and cortisol-associated neutrophil modulation in coronary artery disease patients undergoing stent implantation

Margit Keresztes1, Tamás Horváth, Imre Ocsovszki

  • 1Department of Biochemistry, Medical Faculty, University of Szeged, Szeged, Hungary. keresztes.margit@med.u-szeged.hu

Plos One
|August 23, 2013
PubMed

Insights

Psychosocial stress impacts coronary artery disease (CAD) patients undergoing percutaneous coronary intervention (PCI). This study links stress hormones cortisol and ACTH to neutrophil activation before and after PCI, revealing key associations.

Area of Science:

  • Cardiology
  • Immunology
  • Endocrinology

Background:

  • Psychosocial stress and neutrophil activation are CAD risk factors.
  • The relationship between stress, the hypothalamic-pituitary-adrenal (HPA) axis, and neutrophil activation in percutaneous coronary intervention (PCI) patients is not well understood.
  • This study investigates cortisol and ACTH-associated changes in granulocyte activation during PCI.

Purpose of the Study:

  • To examine the association between stress hormones (cortisol, ACTH) and neutrophil activation in patients undergoing PCI.
  • To explore the dynamics of neutrophil activation and degranulation markers before, immediately after, and one day following PCI.
  • To correlate hormonal changes with specific neutrophil activation markers in stable angina pectoris (SAP) and acute coronary syndrome (ACS) patients.

Main Methods:

  • Blood samples were collected from 21 SAP and 20 ACS patients at pre-PCI, post-PCI, and 1-day post-PCI time points.
  • Flow cytometry was used to analyze granulocyte surface markers (L-selectin, CD15) and intracellular lactoferrin.
  • Plasma levels of cortisol, ACTH, lactoferrin, and IL-6 were measured.

Main Results:

  • Neutrophil lactoferrin parameters were elevated pre- and post-PCI, decreasing significantly by 1 day post-PCI in both groups.
  • Plasma ACTH levels decreased markedly by 1 day post-PCI, particularly in the ACS group.
  • In ACS patients, elevated pre-PCI cortisol correlated with plasma lactoferrin, and post-PCI ACTH negatively correlated with lactoferrin-bearing neutrophils and plasma lactoferrin.

Conclusions:

  • PCI is associated with increased neutrophil activation/degranulation, indicated by elevated lactoferrin.
  • Declines in neutrophil activation markers one day post-PCI correlate with plasma ACTH levels in both patient groups.
  • The correlation between cortisol and lactoferrin in highly stressed ACS patients before PCI suggests a link between cortisol and neutrophil activation.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...